Biohaven

Filed a patent for "trpm3 modulators for treatment of pain" on Mon, August 7, 2023

Filed a patent for "formulations of kv7 channel activators" on Thu, August 10, 2023

Filed a patent for "bifunctional molecules to target degradation of interleukin 17a (il-17a)" on Mon, February 6, 2023

Filed a patent for "administration of fibronectin based scaffold domain proteins to treat overweight, obesity, and related health conditions" on Fri, February 10, 2023

Filed a patent for "reagents for preparation of antibody-drug conjugates" on Sun, April 23, 2023

Filed a patent for "degraders of immunoglobulin g" on Fri, April 28, 2023

Filed a patent for "bifunctional degraders of galactose-deficient immunoglobulins" on Sat, April 29, 2023

Filed a patent for "antibody recruiting molecules for the treatment of coronavirusdisease-19" on Sat, April 29, 2023

Filed a patent for "asialoglycoprotein-binding compoundsand their uses" on Sun, April 30, 2023

Filed a patent for "antibody-drug conjugates for delivering cytotoxic agents" on Fri, May 19, 2023

Filed a patent for "antibody-drug conjugates for delivering cytotoxic agents" on Tue, May 30, 2023

Filed a patent for "bifunctional degraders of galactose-deficient immunoglobulins" on Tue, May 30, 2023

Filed a patent for "degraders of immunoglobulin g" on Mon, August 7, 2023

Filed a patent for "treatment of glioblastoma with prodrugs of riluzole" on Sun, June 26, 2022

Filed a patent for "technologies for preventing or treating infections" on Thu, October 19, 2023

Filed a patent for "compositions and methods for treating obsessive-compulsive disorder" on Thu, June 15, 2023

Filed a patent for "cd16a binding agents and uses thereof" on Thu, February 15, 2024

Filed a patent for "combination therapies including metal channel activators andtdp-43 modulators" on Tue, March 28, 2023

Filed a patent for "agents for directed conjugation techniques and conjugated products" on Tue, October 17, 2023

Filed a patent for "compositions including conjugated therapy enhancers" on Tue, October 17, 2023

Filed a patent for "prodrugs of myeloperoxidase inhibitors" on Thu, February 29, 2024

Filed a patent for "directed conjugation technologies" on Thu, April 27, 2023

Filed a patent for "combination therapies including metal channel activators" on Tue, August 30, 2022

Filed a patent for "combination therapies including metal channel activators" on Tue, September 6, 2022

Filed a patent for "combination therapies including metal channel activators" on Tue, September 6, 2022